CoChat

Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study

Open access

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Previous studies have found associations between the use of central nervous system medication and the risk of cognitive decline in the aged. Our aim was to assess whether the use of a single central nervous system (CNS) medication and, on the other hand, the combined use of multiple CNS medications over time are related to the risk of cognitive decline in an older (≥ 65 yrs) population that is cognitively intact at baseline. METHODS: We conducted a longitudinal population-based study of cognitively intact older adults. The participants were 65 years old or older and had Mini-Mental State Examination (MMSE) sum scores of 24 points or higher. The study included a 7.6-year follow-up. The use of benzodiazepines and related drugs (BZDs), antipsychotics (APs), antidepressants (ADs), opioids (Ops), anticholinergics (AChs) and antiepileptics (AEs) was determined at baseline and after a 7.6-years of the follow-up period. Cognitive functioning was used as an outcome variable measured with MMSE at baseline and at the mean follow-up of 7.6 years. Control variables were adjusted with analyses of covariance. RESULTS: After adjusting for control variables, the use of Ops and the concomitant use of Ops and BZDs as well as the use of Ops and any CNS medication were associated with cognitive decline. The use of AChs was associated with decline in cognitive functioning only in men. CONCLUSIONS: Of all the CNS medications analyzed in this study, the use of Ops may have the greatest effect on cognitive functioning in the ageing population. Due to small sample sizes these findings cannot be generalized to the unselected ageing population. More studies are needed concerning the long-term use of CNS medications, especially their concomitant use, and their potential cognitive effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2318-11-70

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 2

  1. National Agency of Medicines: Classification of Medicines (ATC) and Defined Daily Doses (DDD). 1996, Helsinki
  2. Socialstyrelsen: Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapi [Indicators for evaluating the quality of medication therapy in the aged]. 2003, Stockholm, Report No.: 2003-110-20: 74

Cited by

See all 51

Metadata

Authors
Puustinen, J., Nurminen, J., Löppönen, M., Vahlberg, T., Isoaho, R., Räihä, I., & Kivelä, S.-L.
Affiliations
University of Turku (FI)
Corresponding author
Puustinen, Juha
Venue
BMC Geriatrics
Published
2011-11-01
Volume
11
Issue
1
Pages
70-70
ISSN
1471-2318 (ISSN-L)
OpenAlex
W1993777947
Cited by
51
References
29
Citations by year
2025: 3 · 2024: 5 · 2023: 1 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 6 · 2015: 7 · 2014: 1 · 2013: 4 · 2012: 4
FWCI
1.37
Type
journal article
Language
en
Open access
Locations
  • BMC Geriatrics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
Keywords
central nervous system drugs, cognitive decline, older adults, opioids, benzodiazepines, antipsychotic drugs, antidepressants, anticholinergic agents, antiepileptic drugs, polypharmacy, drug-drug interactions, sex differences, cognitive aging
MeSH terms
Aged, Aged, 80 and over, Analgesics, Opioid, Benzodiazepines, Central Nervous System Agents, Cognition Disorders, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Brief Psychiatric Rating Scale, Population Surveillance, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study. https://app.cochat.ai/papers/10.1186/1471-2318-11-70
The paper
Puustinen, J., Nurminen, J., Löppönen, M., Vahlberg, T., Isoaho, R., Räihä, I., & Kivelä, S.-L. (2011). Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study. BMC Geriatrics. https://doi.org/10.1186/1471-2318-11-70

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.